Benzinga - by Avi Kapoor, Benzinga Staff Writer.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Jefferies analyst Kaumil Gajrawala upgraded The Boston Beer Company, Inc. (NYSE:SAM) from Hold to Buy and increased the price target from $335 to $360. Boston Beer shares declined 2.5% to close at $283.82 on Monday. See how other analysts view this stock.
- JP Morgan analyst Rahul Krotthapalli upgraded the rating on Planet Fitness, Inc. (NYSE:PLNT) from Neutral to Overweight, while boosting the price target from $68 to $78. Planet Fitness shares gained 0.9% to settle at $65.56 on Monday. See how other analysts view this stock.
- Guggenheim analyst Debjit Chattopadhyay upgraded the rating for Amicus Therapeutics, Inc. (NASDAQ:FOLD) from Neutral to Buy and announced a $13 price target. Amicus Therapeutics shares fell 2.1% to settle at $9.04 on Monday. See how other analysts view this stock.
- Baird analyst Eric Coldwell upgraded Fortrea Holdings Inc. (NASDAQ:FTRE) from Neutral to Outperform, but slashed the price target from $45 to $36.. Fortrea Holdings shares fell 14.9% to close at $28.11 on Monday. Fortrea reported soft first-quarter FY24 results and cut its revenue outlook on Monday. See how other analysts view this stock.
- Wells Fargo analyst Neil Kalton upgraded Edison International (NYSE:EIX) from Equal-Weight to Overweight, while raising the price target from $72 to $86. Edison Intl shares slipped 0.6% to settle at $74.44 on Monday. See how other analysts view this stock.
Latest Ratings for SAM
| Feb 2022 | Citigroup | Maintains | Neutral | |
| Feb 2022 | Credit Suisse | Maintains | Outperform | |
| Jan 2022 | RBC Capital | Maintains | Outperform |
View the Latest Analyst Ratings
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.